BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Szymczak JE, Muller BM, Shakamuri NS, Hamilton KW, Gerber JS, Laguio-Vila M, Dumyati GK, Fridkin SK, Guh AY, Reddy SC, Lautenbach E; CDC Prevention Epicenters Program. Prescriber perceptions of fluoroquinolones, extended-spectrum cephalosporins, and Clostridioides difficile infection. Infect Control Hosp Epidemiol 2020;41:914-20. [PMID: 32468967 DOI: 10.1017/ice.2020.183] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Graber CJ. Behavioral change challenges in limiting fluoroquinolone and extended-spectrum cephalosporins to prevent Clostridioides difficile disease. Infect Control Hosp Epidemiol 2020;41:1194-5. [PMID: 32762787 DOI: 10.1017/ice.2020.289] [Reference Citation Analysis]
2 Same RG, Hsu AJ, Cosgrove SE, Klein EY, Amoah J, Hersh AL, Kronman MP, Tamma PD. Antibiotic-Associated Adverse Events in Hospitalized Children. J Pediatric Infect Dis Soc 2021;10:622-8. [PMID: 33452808 DOI: 10.1093/jpids/piaa173] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Livorsi DJ, Suda KJ, Cunningham Goedken C, Hockett Sherlock S, Balkenende E, Chasco EE, Scherer AM, Goto M, Perencevich EN, Goetz MB, Reisinger HS; Veterans Affairs-Centers for Disease Control and Prevention Practice-Based Research Network. The feasibility of implementing antibiotic restrictions for fluoroquinolones and cephalosporins: a mixed-methods study across 15 Veterans Health Administration hospitals. J Antimicrob Chemother 2021;76:2195-203. [PMID: 34015115 DOI: 10.1093/jac/dkab138] [Reference Citation Analysis]
4 Thompson ND, Stone ND, Brown CJ, Penna AR, Eure TR, Bamberg WM, Barney GR, Barter D, Clogher P, DeSilva MB, Dumyati G, Frank L, Felsen CB, Godine D, Irizarry L, Kainer MA, Li L, Lynfield R, Mahoehney JP, Maloney M, Nadle J, Ocampo VLS, Pierce R, Ray SM, Davis SS, Sievers M, Srinivasan K, Wilson LE, Zhang AY, Magill SS. Antimicrobial Use in a Cohort of US Nursing Homes, 2017. JAMA 2021;325:1286-95. [PMID: 33821897 DOI: 10.1001/jama.2021.2900] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
5 Mylotte JM. Decision Tools and Studies to Improve the Diagnosis of Urinary Tract Infection in Nursing Home Residents: A Narrative Review. Drugs Aging 2021;38:29-41. [PMID: 33174126 DOI: 10.1007/s40266-020-00814-6] [Reference Citation Analysis]
6 Suda KJ, Clore GS, Evans CT, Reisinger HS, Kale I, Echevarria K, Sherlock SH, Perencevich EN, Goetz MB; VA-CDC Practice-Based Research Network. Acceptability and effectiveness of antimicrobial stewardship implementation strategies on fluoroquinolone prescribing. Infect Control Hosp Epidemiol 2021;:1-8. [PMID: 33843527 DOI: 10.1017/ice.2021.10] [Reference Citation Analysis]